Literature DB >> 3061698

Neonatal sepsis: the potential for immunotherapy.

J E Baley1.   

Abstract

There is tremendous potential for immunotherapy of neonatal sepsis, considering the continued high mortality of the disease. Current studies, particularly of intravenous immunoglobulin, have had encouraging outcomes. However, much more data need to be accumulated before clinical application.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3061698

Source DB:  PubMed          Journal:  Clin Perinatol        ISSN: 0095-5108            Impact factor:   3.430


  7 in total

Review 1.  Impact of Immunoglobulin Therapy in Pediatric Disease: a Review of Immune Mechanisms.

Authors:  Priscilla H Wong; Kevin M White
Journal:  Clin Rev Allergy Immunol       Date:  2016-12       Impact factor: 8.667

2.  Serum immunoglobulins to endotoxin core glycolipid: establishment of normal concentrations.

Authors:  S K Jackson; J Parton; G Shortland; J M Stark; E N Thompson
Journal:  Arch Dis Child       Date:  1990-07       Impact factor: 3.791

3.  Intravenous immunoglobulin for preventing infection in preterm and/or low birth weight infants.

Authors:  Arne Ohlsson; Janet B Lacy
Journal:  Cochrane Database Syst Rev       Date:  2020-01-29

Review 4.  Considerations in the pharmacologic treatment and prevention of neonatal sepsis.

Authors:  Chris Stockmann; Michael G Spigarelli; Sarah C Campbell; Jonathan E Constance; Joshua D Courter; Emily A Thorell; Jared Olson; Catherine M T Sherwin
Journal:  Paediatr Drugs       Date:  2014-02       Impact factor: 3.022

5.  Intravenous immunoglobulin for suspected or proven infection in neonates.

Authors:  Arne Ohlsson; Janet B Lacy
Journal:  Cochrane Database Syst Rev       Date:  2020-01-29

6.  Efficacy of pentoxifylline treatment for neonatal sepsis: a meta-analysis of randomized controlled studies.

Authors:  Jun Tian; Peifang Shen; Kaiyu Pan; Qiong Zhou
Journal:  Ital J Pediatr       Date:  2019-08-22       Impact factor: 2.638

7.  The INIS Study. International Neonatal Immunotherapy Study: non-specific intravenous immunoglobulin therapy for suspected or proven neonatal sepsis: an international, placebo controlled, multicentre randomised trial.

Authors: 
Journal:  BMC Pregnancy Childbirth       Date:  2008-12-08       Impact factor: 3.007

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.